Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Change in Accured Expenses (2020 - 2025)

Definitive Healthcare's Change in Accured Expenses history spans 6 years, with the latest figure at -$1.4 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 405.61% year-over-year to -$1.4 million; the TTM value through Dec 2025 reached -$1.1 million, up 80.07%, while the annual FY2025 figure was -$1.1 million, 80.07% up from the prior year.
  • Change in Accured Expenses reached -$1.4 million in Q4 2025 per DH's latest filing, down from $12.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $12.5 million in Q3 2025 to a low of -$8.7 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $67300.0, with a median of -$863000.0 recorded in 2024.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 469.72% in 2022, then tumbled 405.61% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $7.4 million in 2021, then crashed by 136.46% to -$2.7 million in 2022, then skyrocketed by 208.35% to $2.9 million in 2023, then tumbled by 109.76% to -$285000.0 in 2024, then crashed by 405.61% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Change in Accured Expenses are -$1.4 million (Q4 2025), $12.5 million (Q3 2025), and -$3.4 million (Q2 2025).